MGRX icon

Mangoceuticals
MGRX

9 hedge funds and large institutions have $440K invested in Mangoceuticals in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

1.17% more ownership

Funds ownership: 1.46% → 2.62% (+1.2%)

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$278K
2
+$47.1K
3
+$16.1K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$10.5K
5
TRCT
Tower Research Capital (TRC)
New York
+$315

Top Sellers

1
-$13.8K
2
-$11.3K
3
-$5.63K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$278K
ACA
2
Ackerman Capital Advisors
Texas
$52.4K
Renaissance Technologies
3
Renaissance Technologies
New York
$47.1K
Geode Capital Management
4
Geode Capital Management
Massachusetts
$40.3K
Goldman Sachs
5
Goldman Sachs
New York
$16.1K
SPIA
6
Steward Partners Investment Advisory
New York
$3.18K
TRCT
7
Tower Research Capital (TRC)
New York
$2.81K
Bank of America
8
Bank of America
North Carolina
$247
UBS Group
9
UBS Group
Switzerland
$120
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Quebec, Canada
–
Osaic Holdings
11
Osaic Holdings
Arizona
–